Protalix BioTherapeutics, Inc. (PLX)
USD 2.62
(8.51%)
USD 2.62
(8.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 65.49 Million | 47.63 Million | 38.35 Million | 62.89 Million | 54.69 Million | 34.24 Million |
| Cost of Revenue | 22.98 Million | 19.59 Million | 16.34 Million | 10.87 Million | 10.89 Million | 9.3 Million |
| Gross Profit | 42.51 Million | 28.04 Million | 22 Million | 52.02 Million | 43.79 Million | 24.93 Million |
| Operating Expenses | 32.05 Million | 41.06 Million | 42.46 Million | 49.31 Million | 54.51 Million | 44.24 Million |
| Selling, General and Administrative Expenses | 14.95 Million | 11.71 Million | 12.72 Million | 11.14 Million | 9.89 Million | 10.91 Million |
| Research and Development Expenses | 17.09 Million | 29.34 Million | 29.73 Million | 38.16 Million | 44.61 Million | 33.33 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 55.03 Million | 60.65 Million | 58.81 Million | 60.18 Million | 65.41 Million | 53.54 Million |
| Operating Income | 10.46 Million | -13.01 Million | -20.46 Million | 1.84 Million | -10.71 Million | -19.3 Million |
| Interest Expense | 3.18 Million | 2.52 Million | 7.52 Million | 9.67 Million | 7.96 Million | 7.68 Million |
| Income Tax Expense | 254 Thousand | 530 Thousand | 6.4 Million | 8.36 Million | 7.96 Million | 536 Thousand |
| Earnings before Tax | 8.56 Million | -14.39 Million | -27.58 Million | -6.52 Million | -18.27 Million | -26.45 Million |
| Net Income | 8.31 Million | -14.92 Million | -33.98 Million | -14.89 Million | -26.24 Million | -26.45 Million |
| Earnings Per Share Basic | 0.12 | -0.31 | -0.77 | -0.51 | -1.77 | -1.80 |
| Earnings Per Share Diluted | 0.10 | -0.31 | -0.77 | -0.51 | -1.77 | -1.80 |
| Weighted Average Shares Outstanding | 67.51 Million | 48.47 Million | 44.14 Million | 29.14 Million | 14.83 Million | 14.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.42 Million | 48.47 Million | 44.14 Million | 29.14 Million | 14.83 Million | 14.71 Million |
| Gross Margin | 0.65 | 0.59 | 0.57 | 0.83 | 0.80 | 0.73 |
| EBIT Margin | 0.18 | -0.23 | -0.52 | 0.05 | -0.16 | -0.55 |
| Profit Margin | 0.13 | -0.31 | -0.89 | -0.24 | -0.48 | -0.77 |
| EBITDA | 11.65 Million | -10.78 Million | -18.94 Million | 4.45 Million | -8.69 Million | -17.1 Million |
| Earnings Before Tax Margin | 0.16 | -0.27 | -0.53 | 0.03 | -0.20 | -0.56 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 13.47 Million | 3.74 Million | 10.48 Million | 65.49 Million | 10.34 Million | 35.07 Million |
| Cost of Revenue | 9.45 Million | 2.6 Million | 8.85 Million | 22.98 Million | 4.89 Million | 6.14 Million |
| Gross Profit | 4.01 Million | 1.14 Million | 1.63 Million | 42.51 Million | 5.45 Million | 28.92 Million |
| Operating Expenses | 6.44 Million | 6 Million | 7.24 Million | 32.05 Million | 7.33 Million | 8.5 Million |
| Selling, General and Administrative Expenses | 3.48 Million | 3.11 Million | 4.14 Million | - | 3.67 Million | 4.03 Million |
| Research and Development Expenses | 2.96 Million | 2.88 Million | 3.1 Million | - | 3.66 Million | 4.47 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 15.9 Million | 8.6 Million | 16.1 Million | 55.03 Million | 7.33 Million | 14.65 Million |
| Operating Income | -2.42 Million | -4.85 Million | -5.61 Million | 10.46 Million | -1.88 Million | 20.42 Million |
| Interest Expense | 367 Thousand | 390 Thousand | 774 Thousand | 3.18 Million | 460 Thousand | 1.3 Million |
| Income Tax Expense | -69 Thousand | -138 Thousand | -382 Thousand | 254 Thousand | 133 Thousand | 308 Thousand |
| Earnings before Tax | -2.27 Million | -4.73 Million | -6.42 Million | 8.56 Million | -1.71 Million | 19.64 Million |
| Net Income | -2.2 Million | -4.59 Million | -6.04 Million | 8.31 Million | -1.85 Million | 19.33 Million |
| Earnings Per Share Basic | -0.03 | -0.06 | -0.08 | - | -0.03 | 0.29 |
| Earnings Per Share Diluted | -0.03 | -0.06 | -0.08 | - | -0.02 | 0.21 |
| Weighted Average Shares Outstanding | 73.3 Million | 73.03 Million | 72.95 Million | 67.51 Million | 72.28 Million | 67.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.3 Million | 73.03 Million | 72.95 Million | 82.42 Million | 83.78 Million | 83.2 Million |
| Gross Margin | 0.30 | 0.31 | 0.16 | 0.65 | 0.53 | 0.82 |
| EBIT Margin | -0.16 | -1.21 | -0.51 | - | -0.18 | 0.60 |
| Profit Margin | -0.16 | -1.23 | -0.58 | 0.13 | -0.18 | 0.55 |
| EBITDA | -2.1 Million | -4.53 Million | -5.3 Million | - | -1.88 Million | 20.95 Million |
| Earnings Before Tax Margin | -0.18 | -1.30 | -0.54 | 0.16 | -0.18 | 0.58 |
CGS
SBTX
KKPNF
RCL
SCC-R
6038